-
White House: Health reform will save Medicare $3,500 per patient
WASHINGTON — Proclaiming the potential cost-saving benefits of its signature legislative accomplishment, the massive health-reform bill enacted earlier this year, the White House is projecting that the Affordable Care Act will reduce average costs per patient enrolled in Medicare by thousands of dollars over the next decade.
-
Bristol-Myers Squibb seeks additional approval for Orencia
PRINCETON, N.J. — The Food and Drug Administration has accepted for review a supplemental approval application for an arthritis drug made by Bristol-Myers Squibb, the drug maker said Monday.
Bristol is seeking approval for Orencia (abatacept) injected into the skin as a treatment for adults with moderate to severe rheumatoid arthritis. The drug already is approved for intravenous injection.